Similar articles for PMID: 19564412

Year	Number of Results
1999	2
2000	1
2001	1
2002	2
2003	1
2004	5
2005	4
2006	7
2007	4
2008	7
2009	16
2010	7
2011	5
2012	6
2013	4
2014	5
2015	7
2016	6
2017	3
2018	3
2019	1
2020	2
2021	1
2022	1
2023	1
2024	0

1

The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.

Farina AR, Tacconelli A, Cappabianca L, Cea G, Panella S, Chioda A, Romanelli A, Pedone C, Gulino A, Mackay AR. Farina AR, et al. Mol Cell Biol. 2009 Sep;29(17):4812-30. doi: 10.1128/MCB.00352-09. Epub 2009 Jun 29. Mol Cell Biol. 2009. PMID: 19564412 Free PMC article.

2

TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.

Farina AR, Di Ianni N, Cappabianca L, Ruggeri P, Ragone M, Ianni G, Gulino A, Mackay AR. Farina AR, et al. Biomed Res Int. 2013;2013:740187. doi: 10.1155/2013/740187. Epub 2013 Jun 6. Biomed Res Int. 2013. PMID: 23841091 Free PMC article.

3

Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.

Farina AR, Cappabianca L, Ruggeri P, Gneo L, Maccarone R, Mackay AR. Farina AR, et al. Oncotarget. 2015 Nov 3;6(34):35636-51. doi: 10.18632/oncotarget.5802. Oncotarget. 2015. PMID: 26415233 Free PMC article.

4

The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.

Farina AR, Tacconelli A, Cappabianca L, Cea G, Chioda A, Romanelli A, Pensato S, Pedone C, Gulino A, Mackay AR. Farina AR, et al. Oncogene. 2009 Nov 19;28(46):4075-94. doi: 10.1038/onc.2009.256. Epub 2009 Sep 7. Oncogene. 2009. PMID: 19734938 Free article.

5

The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.

Farina AR, Cappabianca L, Ruggeri P, Gneo L, Pellegrini C, Fargnoli MC, Mackay AR. Farina AR, et al. J Exp Clin Cancer Res. 2018 Jun 18;37(1):119. doi: 10.1186/s13046-018-0786-3. J Exp Clin Cancer Res. 2018. PMID: 29914559 Free PMC article. Review.

6

The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.

Cappabianca L, Zelli V, Pellegrini C, Sebastiano M, Maccarone R, Clementi M, Chiominto A, Ruggeri P, Cardelli L, Ruggieri M, Sbaffone M, Fargnoli MC, Guadagni S, Farina AR, Mackay AR. Cappabianca L, et al. Cells. 2023 Jan 5;12(2):237. doi: 10.3390/cells12020237. Cells. 2023. PMID: 36672171 Free PMC article.

7

TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.

Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, Vetuschi A, Sferra R, Rucci N, Argenti B, Screpanti I, Gulino A, Mackay AR. Tacconelli A, et al. Cancer Cell. 2004 Oct;6(4):347-60. doi: 10.1016/j.ccr.2004.09.011. Cancer Cell. 2004. PMID: 15488758 Free article.

8

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.

Guadagni S, Farina AR, Cappabianca LA, Sebastiano M, Maccarone R, Zelli V, Clementi M, Chiominto A, Bruera G, Ricevuto E, Fiorentini G, Sarti D, Mackay AR. Guadagni S, et al. Int J Mol Sci. 2020 Nov 3;21(21):8222. doi: 10.3390/ijms21218222. Int J Mol Sci. 2020. PMID: 33153070 Free PMC article.

9

Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.

Tacconelli A, Farina AR, Cappabianca L, Gulino A, Mackay AR. Tacconelli A, et al. Future Oncol. 2005 Oct;1(5):689-98. doi: 10.2217/14796694.1.5.689. Future Oncol. 2005. PMID: 16556046 Review.

10

TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.

Gneo L, Ruggeri P, Cappabianca L, Farina AR, Di Ianni N, Mackay AR. Gneo L, et al. Oncotarget. 2016 Dec 6;7(49):80820-80841. doi: 10.18632/oncotarget.13098. Oncotarget. 2016. PMID: 27821809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year